PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Yolk, also known as In One Basket Limited, is a pioneering company revolutionizing the food and coffee experience for people on the move. They provide high-quality sandwiches, salads, and improved breakfast options without the premium cost, boasting five successful locations in London and three upcoming openings in the second half of 2023
days to go:
TBC
investment:
Withheld
Yumbles is a leading UK online marketplace for artisan food. It currently connects over 600 independent food makers directly with consumers. The company is targeting the UK’s estimated £10bn+ UK Speciality Food & Drink market, having seen £1m+ sales in the last 12 months resulting in £400k+ revenue.
days to go:
Expired
investment:
£262,080
FLY LDN is a fitness brand that imparts sports and fitness instruction via its digital platform and its studios in central London and Fitzrovia. The company launched its video-on-demand and live-streaming fitness platform, FLY LDN Online (FLO), in September 2020. It asserts that within six months of launch, FLO scaled over 28,000 monthly views across 80+ countries with users having viewed over 2.5 million minutes of FLY LDN workouts. FLY LDN won the Men's Health 'Best Studio 2019' award and was commended at the 2018 and 2019 Tatler Gym Awards. The company has also received press coverage in publications like Women's Health, Forbes, Esquire, Elle, Vogue, GQ and Glamour. It has also partnered with brands such as DKNY and ASOS. FLY LDN aspires to become a contender in the global online fitness market that is expected to reach $59 billion by 2027. The company will use the investment to further develop additional functionality and TV apps for FLO and fund marketing campaigns to fuel growth.
days to go:
Expired
investment:
£340,928
Supper aims to be a unique delivery service focusing on quality and service for high-end restaurants. It argues that its commercial metrics and lack of reliance on 'Gig-Economy' workers sets it apart from competitors. The company intends to become a contender in the food delivery market that grew by 35% in 2020 and by almost 150% over the last 5 years. It has partnered with 130 notable establishments such as Zuma, Park Chinois, Milos, and Cova, to name a few. Supper has 61,000 customers on its portal that is further growing by 1,500 new customers every month. The company delivers 1,000 orders each week and has fulfilled 100,000 orders to date with the average order costing £100. It delivers orders via its purpose-built, gyroscopically-stable, and temperature-controlled vehicles. Supper will use the investment to focus on its growth in London and expand globally.
days to go:
Expired
investment:
Withheld
Stem and Glory is a vegan restaurant on a mission to disrupt the restaurant industry by serving plant based food only. They currently have two restaurants and are looking to expand to a flagship restaurant in London.
days to go:
Expired
investment:
£616,170
The Good Egg currently serves over 1000 customers a week after sell out pop-ups and food markets and a successful raise in 2014. They are now raising on Crowdcube again to bring their all-day Montreal-deli-meets-Israeli street-food to Soho's Kingly Court.
days to go:
Expired
investment:
£606,540
